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Disclosure of The Diagnosis of  
alzheimer’s Disease
Caregivers’ opinions in a Brazilian Sample
Marta Maria Shimizu1, I. Raicher1, Daniel Yasumasa Takahashi1,  
Paulo Caramelli1,2, Ricardo Nitrini1 
Abstract – Background: Disclosure of the diagnosis of Alzheimer’s disease (AD) remains a contentious issue, and 
has been little studied in developing countries.  Objective: To investigate the influence of socio-demographic 
factors and the experience of being a caregiver on opinion about disclosing AD diagnosis to the patient in a 
Brazilian sample.  Method: Caregivers of 50 AD patients together with 50 control participants that did not have 
the experience of being a caregiver of AD patient were interviewed using a structured questionnaire.   Results: 
Most of the participants (73.0%) endorsed disclosure of the diagnosis, while caregivers were less prone to 
disclose (58.0%) than controls (88.0%; p=0.0007). Logistic regression confirmed that only the experience of 
being a caregiver was associated with a lesser tendency for disclosure endorsement.  Conclusion: The majority 
of participants was in favor of disclosing the diagnosis, but caregivers were less willing to disclose the diagnosis 
to the AD patient.
Key worDS: Alzheimer’s disease, diagnosis, disclosure, caregiver, dementia.
a revelação do diagnóstico de doença de alzheimer: opiniões de cuidadores em uma amostra brasileira
Resumo – Fundamento: A revelação do diagnóstico de doença de Alzheimer (DA) tem sido tema polêmico 
e pouco estudado em países em desenvolvimento.  Objetivo: Investigar a influência de fatores sócio-
demográficos e a experiência de ter sido cuidador na opinião sobre a revelação do diagnóstico em uma 
amostra brasileira.  Método: Cuidadores de 50 pacientes com DA e 50 indívíduos controle que não tinham 
tido experiência como cuidadores de pacientes com DA foram entrevistados com o uso de um questionário 
estruturado.  Resultados: A maioria dos participantes (73,0%) manifestou-se a favor da revelação diagnóstico 
aos pacientes, mas cuidadores foram menos favoráveis (58,0%) que controles (88,0%; p=0,0007). regressão 
logística demonstrou que apenas a experiência como cuidador foi associada com menor tendência a apoiar a 
revelação do diagnóstico.  Conclusão: A maioria dos participantes foi a favor da revelação do diagnóstico ao 
paciente, mas aqueles com experiência como cuidadores de pacientes com DA foram menos favoráveis. 
PALAvrAS-ChAve: doença de Alzheimer, diagnóstico, revelação, cuidador, demência.
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The population worldwide has undergone an aging 
process that has led to an increasing prevalence of chron-
ic illnesses, such as Alzheimer’s disease (AD)1-3. Therefore, 
the ethical issues concerning this disease, which impairs 
not only patient quality of life, but also of those around 
them, have come to the fore4-7. AD is a progressive neu-
rological illness causing the decline of the patient’s cog-
nitive abilities, including memory, judgment, orientation 
and attention, eventually rendering them fully dependent 
on external care. Psychiatric symptoms, mainly depression 
and agitation, are also very frequent. AD onset common-
ly occurs at the age of 65 years onwards and entails a sig-
nificant shortening of the patient’s lifespan8,9. In so far as 
AD is a degenerative disease bearing a somber progno-
sis, the disclosure of the diagnosis to the patients repre-
sents a polemic issue for their families10-13. Studies investi-
gating the question of disclosure have found differing re-
sults. In Ireland, from a cohort of 100 relatives of AD pa-
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tients, only 17 relatives stated the patient should be told 
the diagnosis of this disease, whereas the remaining 83 
stated patients should not be told. The main rationale be-
hind the latter stance was that depression would accrue 
in the patient should their diagnosis be disclosed to them. 
however, 71 relatives said they would rather the diagno-
sis of the disease be disclosed to them should they be AD 
suffers, where the majority stated they had the right to 
know so as to enable them to make the proper arrange-
ments for the future in order to ease the coming burden 
on their families14.
Contrasting with the results from Ireland, a study in 
england showed that 57% of the first degree relatives of 
AD patients wanted the diagnosis to be disclosed to their 
ill relative15. In another study in the US, disclosure of the 
diagnosis of AD correlated with the knowledge people 
had of the disease. In this study, about half of the 57 rel-
atives, members of community societies which provided 
assistance to families of patients with dementia, stated 
they were not given enough information about the dis-
ease. Most relatives believed the patients should be told 
of their disease diagnosis and prognosis by the physician, 
despite the fact that half of the relatives informed that 
patients had reacted badly to the disclosure and that only 
one-third of the relatives had felt the disclosure had been 
of any use to the patient16. In Italy, semi-structured inter-
views were given to the closest relatives of 71 patients 
with recent diagnosis of AD. Forty three (60.6%) relatives 
spontaneously declared their wish for patients not to be 
informed of the diagnosis. Following the interview, all in-
terviewees felt the patient should not be told of the diag-
nosis, fearing bringing on or worsening depressive symp-
toms for the patients17. This result is similar to that found 
in Ireland by Conor et al., showing that this fear of the 
emotional impact on the patient following disease diag-
nosis disclosure is prevalent among patient relatives14. To 
date, few studies have been carried out on disclosure of 
the diagnosis of dementia in Brazil and in Latin Ameri-
ca18-20. In Brazil, caregivers of 20 AD patients followed in 
a public university hospital were compared with caregiv-
ers of 20 patients treated in a private clinic, looking for 
possible differences in the wish to disclose. Less than half 
(42.5%) of all the caregivers favored disclosure of the di-
agnosis to the patient, and there was no influence of the 
socioeconomic status in their opinion. however, the study 
in question did not investigate the influence of schooling 
or knowledge of AD18. In another recent study conduct-
ed in Brazil by our group, a letter was sent to neurologists, 
psychiatrists and geriatricians asking whether they usually 
disclose the diagnosis to their patients. Among 181 physi-
cians who answered, 44.7% informed that they regularly 
provide the diagnosis to AD patients20.
This study had the objectives of investigating the opin-
ion of a Brazilian sample of participants on the disclosure 
of AD diagnosis, searching for the influence of socio-de-
mographic factors, mainly schooling, and of the experi-
ence of being a caregiver on the wish to disclose the di-
agnosis to a relative afflicted by AD, and to provide data 
for comparisons with other studies carried out in differ-
ent countries. 
meThoD
The caregivers of patients with the diagnosis of probable AD, 
according to the National Institute of Neurological and Com-
municative Disorders and Stroke – Alzheimer Disease and re-
lated Disorders Association (NINCDS-ADrDA) criteria21 followed 
by members of the Behavioral and Cognitive Neurology Group 
Unit of the hospital das Clínicas of the University of São Paulo 
School of Medicine, in Brazil, and a equivalent number of partic-
ipants without AD cases in their families were interviewed. The 
structured questionnaire used in Japan by Mimura22 comprising 
14 questions related to caregivers’ opinions on the disclosure of 
AD diagnosis was translated into Portuguese by both a physician 
and a student of Medicine who were fluent in both Portuguese 
and Japanese. Subsequently, all arising disagreements in transla-
tions were resolved through a consensus between the two phy-
sicians. Another questionnaire was created to evaluate the gen-
eral knowledge on AD symptoms and course of the disease. The 
questionnaires were made up of multiple choice tests. The Bra-
zilian ABIPeMe (Brazilian Association of Market research Insti-
tute) questionnaire was also applied to assess the socioeconom-
ic status of the interviewees. After this, an informative text on 
AD, containing an explanation of disease symptoms and course, 
was read to each interviewee after which, they were questioned 
again on disclosure of diagnosis to the patient. 
The influence of schooling, age, gender, and socioeconom-
ic status on the wish to disclosure of diagnosis was assessed. It 
was evaluated whether the wish for or against disclosing would 
be modified after having received more information on the dis-
ease, and whether the existence of a real patient with AD in the 
family would interfere with the interviewee’s standpoint. 
The knowledge of AD was probed and whether this bore any 
influence on schooling. The interviewees’ own wish on the dis-
closure of the diagnosis to them should they themselves have 
AD was also verified. 
The study was also intended to make a qualitative analysis 
of the interviewee’s answers to the open questions on the dis-
closure of the diagnosis and to this end the answers of the care-
givers and controls were assessed separately.
The data were stored in a Microsoft excel Table. Categori-
cal data were tested for the independence between the cate-
gories and statistical analyses were carried out with the Fisher 
exact test for 2 × 2 contingency tables, and the two-sided exact 
test23 for bigger contingency tables. Student t test was used for 
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comparison of the mean values for continuous variables. As in 
the multivariate analyses, logistic regression was performed in 
order to verify the factors interfering with the wish to disclose 
the diagnosis. The statistical software ©SPSS version 10.0.1 (SPSS 
Inc), ®Minitab 15 (State College, Pennsylvania, USA, 1983) were 
used. The value of significance accepted was 0.05. 
The study was approved by the ethics and research Commit-
tee of the institution, and the questionnaires were applied after 
reading out and signing of the informed consent. 
resulTs
we were able to interview 50 caregivers (of 50 patients 
with AD) and 50 participants without AD cases in their 
families, comprising 34 men and 66 women, with mean 
age of 57.97 years (SD=11.53) and mean schooling of 8.93 
years (SD=4.77), with a median of 10 years of schooling. 
when all interviewees were jointly assessed, 73% were 
in favor of disclosing the diagnosis to an AD patient. Age, 
gender and socioeconomic level did not influence this 
Table 1. Influence of education (years of schooling), age, gender and socioeconomic level on the 
wish of disclosing AD diagnosis to a patient.
Disclosure of the diagnosis to the patient
pyes No Total
education
    <10 years
    ≥10 years
39 (82.98%)
34 (64.15%)
8 (17.02%)
19 (35.85%)
47
53
0.028
Age
    <56 years
    ≥56 years
30 (68.18%)
43 (76.79%)
14 (31.82%)
13 (23.21%)
44
56
0.113
Gender
  Men
  women
27 (79.41%)
46 (69.70%)
7 (20.59%)
20 (30.30%)
34
66
0.214
*Socioeconomic level
  A
  B
  C
  D
  e
10
25
29
9
0
8
10
8
1
0
18
35
37
10
0
0.214
*If by collapsing categories A and B and categories C, D and e two categories are built, the p-value for Fisher 
exact test for 2 × 2 contigency table is 0.046. 
Table 2. Demographic characteristics of caregivers and control subjects.
Caregivers Control subjects p
education (years of schooling)
  Mean (standard-deviation)
  Median
  range
10.06 (4.80)
11
0–16
7.80 (4.51)
8
0–17
0.017
Age
  Mean (standard-deviation)
  Median
  range
59.66 (13.17)
57
21–85
56.28 (9.44)
56
32–75
0.144
Gender
  Men
  women
14 (28.00%)
36 (72.00%)
20 (40.00%)
30 (60.00%)
0.2053
Socioeconomic level
  A
  B
  C
  D
  e
12 (24.00%)
20 (40.00%)
15 (30.00%)
3 (6.00%)
0
6 (12.00%)
15 (30.00%)
22 (44.00%)
7 (14.00%)
0
0.131
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Table 3. Relatives caregivers and controls’ opinion on disclosure of the diagnosis, and care for the patient (questionnaire originally 
proposed in Japan, by Mimura et al). 
Caregivers Control group p
Main justification for disclosing the diagnosis to the patient:
  It is a right of the patient to know his diagnosis
  The patient can overcome the setback of knowing the diagnosis of his disease
  It is necessary to start with the medication
  The patient already knows the diagnosis of his disease
  others
15 (51.72%)
1 (3.45%)
10 (34.48%)
1 (3.45%)
2 (6.90%)
25 (56.82%)
6 (13.64%)
9 (20.45%)
3 (6.82%)
1 (2.27%)
0.351
Main justification for not disclosing the diagnosis to the patient:
  The patient can become depressed or shocked after knowing the diagnosis
  The patient is not able to understand the meaning of the diagnosis
  Knowing the diagnosis has no meaning
  The patient is afraid of getting the AD
  others
13 (61.91%)
7 (33.33%)
1 (4.76%)
0
0
2 (33.33%)
2 (33.33%)
0
1 (16.67%)
1 (16.67%)
0.131
Main justification for the will of having the diagnosis of his illness disclosed to himself.
  would like to know the treatments and information about the disease
  To be informed of the diagnosis is one’s right
  To get prepared for the aging
  would like to settle the issues related to assets legacy in advance
  others
23 (51.11%)
16 (35.56%)
5 (11.11%)
1 (2.22%)
0
23 (46.94%)
18 (36.73%)
6 (12.25%)
1 (2.04%)
1 (2.04%)
0.989
Main justification for the will of not having the diagnosis of his illness disclosed to himself.
  would get depressed or shocked after knowing the diagnosis
  Knowing the diagnosis has no meaning
4 (80.00%)
1 (20.00%)
1 (100%)
0
0.833
Where would you like to be cared?
  In a institutuion
  At home
23 (28.95%)
27 (71.05%)
23 (46.00%)
27 (54.00%)
0.159
By whom?
  relative
  Professional
14 (36.84%)
24 (63.16%)
17 (34.00%)
33 (66.00%)
0.171
What is your marital status?
  Married
  Single
  widow
  Divorced
36 (72.00%)
7 (14.00%)
5 (10.00%)
2 (4.00%)
31 (62.00%)
6 (12.00%)
4 (8.00%)
9 (18.00%)
0.169
What is your source of revenue?
  Do paidwork daily
  Do paidwork sometimes
  Do not do paidwork
12 (24.00%)
7 (14.00%)
31 (62.00%)
12 (24.00%)
4 (8.00%)
34 (68.00%)
0.689
opinion, while higher schooling was associated with a 
stronger wish of not revealing the diagnosis (Table 1). 
Table 2 shows the demographic characteristics of the 
sample when divided into caregivers and controls. Age, 
gender and socioeconomic level did no differ between 
the groups, but caregivers had higher schooling than con-
trols. Among the caregivers, 58% decided on disclosing 
the diagnosis to the AD patient, whereas among the con-
trols, the number rose to 88% (p=0.0007). other socio-de-
mographic variables, including schooling, were not asso-
ciated with any trend towards disclosure or non-disclo-
sure of the diagnosis to the patient. when the socioeco-
nomical level were divided into only two levels, those in 
the lower level where more prone to disclose the diagno-
sis than those in the upper level (p=0.046). 
reading of the informative text did not modify the 
results (p=0.68 among the caregivers and p=0.40 among 
the controls). 
Logistic regression showed that only the real experi-
ence as a caregiver (β= –1.670 (0.521); odds ratio= 0.188; 
95% CI, 0.680-0.523; p=0.001) was associated with the wish 
for non-disclosure of the diagnosis compared with the hy-
pothetical situation, while schooling, age, gender and so-
cioeconomic level were not associated. 
In the caregiver group, 90% of the interviewees would 
like to have the diagnosis revealed to them should they 
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have AD, and 98% of the controls expressed the same wish 
(p=0.092) (Table 3). AD was considered a reversible disease 
by 18% of the caregivers and by 52% of the subjects without 
AD cases in the family (p=0.0003), whereas 48% of care-
givers and 82% of the control group thought the disease 
did not shorten the patient’s lifespan (p= 0.159) (Table 4). 
Discussion
The main finding of this study was that the majority 
of the interviewed subjects opted to disclose the diag-
nosis to the patient with AD. This finding contrasts with 
results found in Ireland14 and Italy17, yet is similar to those 
reported in the USA16 and england15.
however, caregivers were less likely than controls to 
disclose the AD diagnosis, 42% of them stating that the 
diagnosis should not be disclosed to their ill relative. on 
the other hand, the degree of schooling did not bear any 
relationship with the wish to reveal the diagnosis. These 
results suggest that the factor truly determinant of the 
wish to prevent the patient from knowing the diagnosis 
of their own disease is the real life experience as a care-
giver, whereby people who did not experience AD cases 
in their own families held a view which differs from that 
of caregivers of AD patients. The impact of personal ex-
perience with AD in reducing the attitude toward disclos-
ing the diagnosis had been previously reported in elderly 
American subjects24.
In this study we expected people with higher school-
ing and even from the upper socioeconomic levels to 
exhibit behavior more akin to that seen in developed 
countries, approving the disclosure of the diagnosis to 
the patient with AD. we found the opposite: in the uni-
variate analysis participants with higher educational level 
and from the upper socioeconomic level were less willing 
to disclose the diagnosis to the diseased relative. Nev-
ertheless, in the logistic regression, only the experience 
of being a caregiver was associated with the wish of not 
disclosing the diagnosis. It is upheld here the somewhat 
trivial understanding that culture bears greater influence 
than schooling and that conducts coming from the expe-
rience acquired in other countries should not be defined 
for our milieu. Furthermore, use of generalizations such as 
a prevailing Catholic religion, such as in Ireland and Italy 
or “Latin origin” to infer trends in our population proved 
inappropriate in this case.
Caregivers had better knowledge about AD and even 
so showed greater tendency to spare the patient the dis-
closure of this diagnosis compared with those without 
cases of AD in their families. This finding is important, 
reflecting that revealing the diagnosis in our milieu, does 
not depend on knowledge about the disease. on the 
contrary, greater theoretical knowledge and real-life ex-
perience increased the trend towards not disclosing it. 
however, the finding that more than half of the caregiv-
ers thought the AD diagnosis should be disclosed to the 
patient represents an important fact to be considered by 
the doctor in decision-making in our context.
There are limitations in this study. The number of care-
givers probably was small for reaching a more definitive 
conclusion on the importance of socio-demographic fac-
tors. on the other hand, we did not investigate the im-
portance of the severity of the disease on the wish to 
reveal the diagnosis. In a study, the only factor that was 
associated with the wish of not telling the diagnosis was 
a score in the Mini-Mental State examination below 1725. 
It is probable that for mild AD, or even for mild cognitive 
impairment, the wish to disclose the diagnosis in an Brazil-
ian sample would be different than those reported herein. 
The main justifications for not disclosing the diagnosis 
to the patient were the fear of worsening or leading to 
depression and the knowledge that due to the cognitive 
deficits brought about by AD itself they would unable to 
grasp the meaning of the diagnosis. Nevertheless, most 
of the people interviewed in this study would want their 
own diagnosis revealed to them should they suffer from 
AD. This somewhat conflicting aspect, had already been 
noted in studies carried out in Italy17 and Ireland14, as well 
as by specialized physicians interviewed in our previous 
study in Brazil20. This may reflect differences in schooling, 
or even culture, between the over-65 year-old generation 
and their offspring. 
Table 4. Opinion on the prognosis of Alzheimer’s disease.
Caregivers Control group p
Course of the disease:
  Think there is cure.
  Think that gets worse as time goes by.
  Think that AD does not get worse along the time but the patient keeps having symptoms.
9 (18.00%)
40 (80.00%)
1 (2.00%)
26 (52.00%)
18 (36.00%)
6 (12.00%)
<0.001
The AD patient in your opinion:
  will be able to keep his daily activities normally in the future.
  will get wholly dependent on other people to do his daily activities.
2 (4.00%)
48 (96.00%)
7 (14.00%)
43 (86.00%)
0.064
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